Multimodal molecular study of active pathophysiological pathways of blast injury and neurotrauma in military tactical training operations

The Bronx Veterans Medical Research Foundation, Inc. (BVMRF) received a $1.96M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct a multimodal molecular study examining active pathophysiological pathways of blast injury and neurotrauma in military tactical training operations. The award, effective September 15, 2025, through September 14, 2029, supports advanced biomedical research designed to develop innovative medical solutions addressing critical health challenges relevant to military personnel. The research will be conducted at BVMRF's facilities in the Bronx, New York, leveraging the organization's established expertise in specialized medical investigations and laboratory analysis services for veteran-specific health conditions.

Under the Military Medical Research and Development program, BVMRF will deliver research and development services focused on understanding blast injury mechanisms and neurotrauma pathophysiology through multimodal molecular investigation. This research aligns with the DHA's broader mission to transform healthcare for service members through hypothesis-driven, innovative biomedical research. The project represents a typical award under this program, which supports a portfolio of basic, applied, and advanced research initiatives with performance periods of two to four years and funding ranges from approximately $100,000 to $20 million for consortium awards.